The major mechanism by which SSeCKS is thought to manifest its metastasis-suppressing activity in tumor cells is through its ability to scaffold key signaling mediators in a spatiotemporal manner [1], partly facilitated by SSeCKS containing binding domains for plasma membrane sites as well as for F-actin [31, 32]. Here, AKAP12 is linked to neoplasm.